4.2 Article Proceedings Paper

A basic study design for expedited safety signal evaluation based on electronic healthcare data

期刊

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
卷 19, 期 8, 页码 858-868

出版社

WILEY
DOI: 10.1002/pds.1926

关键词

healthcare databases; cohort study; incident user design; propensity scores; pharmacoepidemiology; Sentinel System

资金

  1. CCR NIH HHS [RC1-RR028231] Funding Source: Medline
  2. NCRR NIH HHS [RC1 RR028231-02, RC1 RR028231] Funding Source: Medline
  3. NLM NIH HHS [R01 LM010213-02, R01-LM010213, R01 LM010213, RC1 LM010351-02, RC1-LM010351, RC1 LM010351] Funding Source: Medline

向作者/读者索取更多资源

Active drug safety monitoring based on longitudinal electronic healthcare databases (a Sentinel System), as outlined in recent FDA-commissioned reports, consists of several interlocked processes, including signal generation, signal strengthening, and signal evaluation. Once a signal of a potential drug safety issue is generated, signal strengthening and signal evaluation have to follow in short sequence in order to quickly provide as much information about the triggering drug-event association as possible. This paper proposes a basic study design based on the incident user cohort design for expedited signal evaluation in longitudinal healthcare databases. It will not resolve all methodological issues nor will it fit all study questions arising within the framework of a Sentinel System. It should rather be seen as a guidance that will fit the majority of situations and serve as a starting point for adaptations to specific studies. Such an approach will expedite and structure the process of study development and highlight specific assumptions, which is particularly valuable in a Sentinel System where signals are by definition preliminary and evaluation of signals is time critical. Copyright (C) 2010 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据